Investing.com -- Morgan Stanley downgraded CrowdStrike (NASDAQ: CRWD) to Equal-weight from Overweight in a note Monday, cautioning that the cybersecurity firm’s shares "look full" following a sharp ...

Cirsa has demonstrated strong operating performance, with revenue and company-adjusted EBITDA growth of 12% and 9% respectively in Q1 2025. Moody’s expects the company’s EBITDA to continue growing at ...

Investing.com -- Hims & Hers CEO Andrew Dudum has shared new information about the company’s terminated partnership with Novo Nordisk (NYSE: NVO ), which ended in June 2025, in an interview with The ...